MX2022000444A - Un biomarcador para la enfermedad de alzheimer utilizando muestras de sangre de sujetos con diagnostico clinico de la enfermedad de alzheimer. - Google Patents
Un biomarcador para la enfermedad de alzheimer utilizando muestras de sangre de sujetos con diagnostico clinico de la enfermedad de alzheimer.Info
- Publication number
- MX2022000444A MX2022000444A MX2022000444A MX2022000444A MX2022000444A MX 2022000444 A MX2022000444 A MX 2022000444A MX 2022000444 A MX2022000444 A MX 2022000444A MX 2022000444 A MX2022000444 A MX 2022000444A MX 2022000444 A MX2022000444 A MX 2022000444A
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- alzheimer
- biomarker
- blood samples
- detection
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invención divulga un método para diagnosticar la enfermedad de Alzheimer mediante el uso de biomarcadores, y el análisis multivariante que da un método de detección más fiable, mínimamente o no invasivo. La invención divulga la detección simultánea de la proteína CD69 en los linfocitos mitógenos, de las proteínas tau y tau fosforilada, y de los péptidos amiloides-ß en el líquido cefalorraquídeo, lo cual puede sustituir o complementar los métodos convencionales de detección de la enfermedad de Alzheimer, como las pruebas cognitivas y la tomografía por emisión de positrones de amiloide.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962872567P | 2019-07-10 | 2019-07-10 | |
| PCT/IB2020/056509 WO2021005568A1 (en) | 2019-07-10 | 2020-07-10 | A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022000444A true MX2022000444A (es) | 2022-02-10 |
Family
ID=74114470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022000444A MX2022000444A (es) | 2019-07-10 | 2020-07-10 | Un biomarcador para la enfermedad de alzheimer utilizando muestras de sangre de sujetos con diagnostico clinico de la enfermedad de alzheimer. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220260595A1 (es) |
| JP (1) | JP2022545153A (es) |
| KR (1) | KR20220034769A (es) |
| CN (1) | CN114174830A (es) |
| BR (1) | BR112022000322A2 (es) |
| CA (1) | CA3144876A1 (es) |
| MX (1) | MX2022000444A (es) |
| WO (1) | WO2021005568A1 (es) |
| ZA (1) | ZA202201448B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11621087B2 (en) * | 2019-09-24 | 2023-04-04 | International Business Machines Corporation | Machine learning for amyloid and tau pathology prediction |
| CN117210549A (zh) * | 2023-08-29 | 2023-12-12 | 河络新图生物科技(上海)有限公司 | 检测人atp5d、cd69和cxcr4基因的物质及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10349162A1 (de) * | 2003-10-22 | 2005-06-02 | Universität Leipzig | Schnelltest zur Diagnose der Alzheimerschen Erkrankung |
| US20130164217A1 (en) * | 2011-12-21 | 2013-06-27 | Meso Scale Technologies, Llc | Method of diagnosing, preventing and/or treating dementia & related disorders |
| JP2015511014A (ja) * | 2012-03-13 | 2015-04-13 | ヤンセン アルツハイマー イミュノセラピー | アルツハイマー病の診断、予後および監視におけるオリゴマー型Ａβ |
-
2020
- 2020-07-10 BR BR112022000322A patent/BR112022000322A2/pt not_active Application Discontinuation
- 2020-07-10 US US17/625,344 patent/US20220260595A1/en active Pending
- 2020-07-10 JP JP2021577534A patent/JP2022545153A/ja active Pending
- 2020-07-10 CA CA3144876A patent/CA3144876A1/en active Pending
- 2020-07-10 MX MX2022000444A patent/MX2022000444A/es unknown
- 2020-07-10 CN CN202080049419.XA patent/CN114174830A/zh active Pending
- 2020-07-10 KR KR1020227000625A patent/KR20220034769A/ko unknown
- 2020-07-10 WO PCT/IB2020/056509 patent/WO2021005568A1/en active Application Filing
-
2022
- 2022-02-01 ZA ZA2022/01448A patent/ZA202201448B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022545153A (ja) | 2022-10-26 |
| ZA202201448B (en) | 2022-09-28 |
| CN114174830A (zh) | 2022-03-11 |
| US20220260595A1 (en) | 2022-08-18 |
| KR20220034769A (ko) | 2022-03-18 |
| BR112022000322A2 (pt) | 2022-02-22 |
| CA3144876A1 (en) | 2021-01-14 |
| WO2021005568A1 (en) | 2021-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3260866B1 (en) | Novel biomarkers for cognitive impairment and methods for detecting cognitive impairment using such biomarkers | |
| WO2009152607A8 (en) | Methods and kits for diagnosing neurodegenerative disease | |
| German et al. | Serum biomarkers for Alzheimer's disease: proteomic discovery | |
| TW200801515A (en) | Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB) | |
| MX2022000444A (es) | Un biomarcador para la enfermedad de alzheimer utilizando muestras de sangre de sujetos con diagnostico clinico de la enfermedad de alzheimer. | |
| CA3005784C (en) | Lactoferrin for use in the diagnosis or prognosis of alzheimer's disease, or in the diagnosis of parkinson's disease | |
| DK2444814T3 (en) | Biomarker for mental disorders, including cognitive disorders, and method of using the biomarker for detecting mental disorders, including cognitive disorders | |
| KR20190026743A (ko) | 경도 인지 장해 또는 알츠하이머형 인지증의 평가 방법 | |
| EP4257982A3 (en) | Biomarkers for the diagnosis of lung cancers | |
| JP2019191192A (ja) | 糖尿病を判定するための血液試料の分析方法及びシステム | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| EP2894477A1 (en) | Method for determining breast cancer | |
| CN109073661B (zh) | 用于神经学疾病的诊断的测定法 | |
| US11543418B2 (en) | Biomarker for cognitive dysfunction disease and method for detecting cognitive dysfunction disease using biomarker | |
| KR20180112639A (ko) | 알츠하이머성 치매의 조기진단을 위한 펩타이드 프로브 | |
| US20110091991A1 (en) | Protein Biomarkers for Alzheimer's Disease Detection | |
| WO2016143805A1 (ja) | 膀胱がんの検出方法 | |
| JP6639457B2 (ja) | 脳脊髄液中のアルブミン酸化還元レベルに基づくアルツハイマー病のインビトロ診断方法 | |
| JP7434678B2 (ja) | 認知症又はそのリスクの検査方法 | |
| Schwarz et al. | Biochemical identification of Vitamin B12 deficiency in a medical office | |
| WO2022133107A8 (en) | Methods for diagnosing alzheimer's disease and other neurological disorders | |
| TW200942819A (en) | Alzheimer's disease-specific alterations of the ErK1/ErK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB) | |
| WO2020153759A3 (ko) | 요로결석 진단을 위한 분석방법 및 키트 | |
| CN115667927A (zh) | 认知症诊断用生物标志物 | |
| NZ791967A (en) | In vitro method for diagnosing central nervous system injury |